Clinical Application of “Ningbitai Capsule” in Women Undergoing Urethral Polyp Electrosection: A report of 60 Cases
JU Bao-ju
Abstract
JU Bao-ju
Abstract
One hundred of women undergoing urethral polyp electrosection were randomized into two groups: treatment group in which 60 cases were given “Ningbitai Capsule” and Levofloxacin Tablets and control group in which 40 cases were given Levofloxacin Tablet only, with a course of 5-7 days. Results: The cure rate and total effective rate were respectively 78.33% and 93.33% in treatment group, and 65.00% and 82.50% in control group, with significant differences between them (P0.05); the disappearance periods of urinary irritating symptoms and hematuria were shorter in treatment group than in control group (P0.05).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
One hundred of women undergoing urethral polyp electrosection were randomized into two groups: treatment group in which 60 cases were given “Ningbitai Capsule” and Levofloxacin Tablets and control group in which 40 cases were given Levofloxacin Tablet only, with a course of 5-7 days. Results: The cure rate and total effective rate were respectively 78.33% and 93.33% in treatment group, and 65.00% and 82.50% in control group, with significant differences between them (P0.05); the disappearance periods of urinary irritating symptoms and hematuria were shorter in treatment group than in control group (P0.05).
Key concepts: Medicine, Capsule, Levofloxacin, Cure rate, Surgery, Urinary system, Urinary retention, Clinical efficacy